vs
Side-by-side financial comparison of BlackSky Technology Inc. (BKSY) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $35.2M, roughly 1.1× BlackSky Technology Inc.). BlackSky Technology Inc. runs the higher net margin — -2.5% vs -161.8%, a 159.3% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 15.9%).
BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
BKSY vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $38.3M |
| Net Profit | $-868.0K | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | -11.8% | -169.0% |
| Net Margin | -2.5% | -161.8% |
| Revenue YoY | 15.9% | 407.0% |
| Net Profit YoY | 95.5% | -4.7% |
| EPS (diluted) | $0.04 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | $38.3M | ||
| Q3 25 | $19.6M | $32.1M | ||
| Q2 25 | $22.2M | $26.4M | ||
| Q1 25 | $29.5M | $16.5M | ||
| Q4 24 | $30.4M | $7.6M | ||
| Q3 24 | $22.5M | $6.1M | ||
| Q2 24 | $24.9M | — | ||
| Q1 24 | $24.2M | — |
| Q4 25 | $-868.0K | $-61.9M | ||
| Q3 25 | $-15.3M | $-67.3M | ||
| Q2 25 | $-41.2M | $-92.6M | ||
| Q1 25 | $-12.8M | $-129.6M | ||
| Q4 24 | $-19.4M | $-59.2M | ||
| Q3 24 | $-12.6M | $-85.7M | ||
| Q2 24 | $-9.4M | — | ||
| Q1 24 | $-15.8M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -11.8% | -169.0% | ||
| Q3 25 | -85.8% | -173.5% | ||
| Q2 25 | -62.8% | -269.8% | ||
| Q1 25 | -40.5% | -390.1% | ||
| Q4 24 | -20.0% | -919.0% | ||
| Q3 24 | -58.7% | -1314.3% | ||
| Q2 24 | -47.0% | — | ||
| Q1 24 | -54.7% | — |
| Q4 25 | -2.5% | -161.8% | ||
| Q3 25 | -78.2% | -209.8% | ||
| Q2 25 | -185.8% | -350.3% | ||
| Q1 25 | -43.4% | -784.9% | ||
| Q4 24 | -63.9% | -783.4% | ||
| Q3 24 | -55.8% | -1404.0% | ||
| Q2 24 | -37.7% | — | ||
| Q1 24 | -65.2% | — |
| Q4 25 | $0.04 | $-0.06 | ||
| Q3 25 | $-0.44 | $-0.07 | ||
| Q2 25 | $-1.27 | $-0.10 | ||
| Q1 25 | $-0.42 | $-0.15 | ||
| Q4 24 | $-0.61 | $-0.08 | ||
| Q3 24 | $-0.66 | $-0.14 | ||
| Q2 24 | $-0.52 | — | ||
| Q1 24 | $-0.88 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $124.5M | $242.8M |
| Total DebtLower is stronger | $201.1M | — |
| Stockholders' EquityBook value | $94.9M | $-500.5M |
| Total Assets | $386.2M | $501.9M |
| Debt / EquityLower = less leverage | 2.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $124.5M | $242.8M | ||
| Q3 25 | $146.5M | $257.8M | ||
| Q2 25 | $93.8M | $153.7M | ||
| Q1 25 | $75.8M | $61.6M | ||
| Q4 24 | $52.5M | $149.8M | ||
| Q3 24 | $63.2M | $130.4M | ||
| Q2 24 | $41.2M | — | ||
| Q1 24 | $35.4M | — |
| Q4 25 | $201.1M | — | ||
| Q3 25 | $195.1M | — | ||
| Q2 25 | $122.5M | — | ||
| Q1 25 | $115.3M | — | ||
| Q4 24 | $107.7M | — | ||
| Q3 24 | $98.8M | — | ||
| Q2 24 | $108.6M | — | ||
| Q1 24 | $85.0M | — |
| Q4 25 | $94.9M | $-500.5M | ||
| Q3 25 | $91.1M | $-524.3M | ||
| Q2 25 | $86.6M | $-570.7M | ||
| Q1 25 | $88.8M | $-591.4M | ||
| Q4 24 | $94.0M | $-489.1M | ||
| Q3 24 | $110.3M | $-745.1M | ||
| Q2 24 | $76.5M | — | ||
| Q1 24 | $81.7M | — |
| Q4 25 | $386.2M | $501.9M | ||
| Q3 25 | $380.9M | $519.0M | ||
| Q2 25 | $310.8M | $402.1M | ||
| Q1 25 | $284.9M | $303.8M | ||
| Q4 24 | $254.1M | $382.9M | ||
| Q3 24 | $245.5M | $364.6M | ||
| Q2 24 | $224.3M | — | ||
| Q1 24 | $210.1M | — |
| Q4 25 | 2.12× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.41× | — | ||
| Q1 25 | 1.30× | — | ||
| Q4 24 | 1.15× | — | ||
| Q3 24 | 0.90× | — | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | 1.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.3M | $-70.4M |
| Free Cash FlowOCF − Capex | — | $-71.3M |
| FCF MarginFCF / Revenue | — | -186.2% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.3M | $-70.4M | ||
| Q3 25 | $-39.0M | $-68.9M | ||
| Q2 25 | $-7.3M | $-79.7M | ||
| Q1 25 | $27.2M | $-85.9M | ||
| Q4 24 | $-1.8M | $-85.1M | ||
| Q3 24 | $1.0M | $-98.8M | ||
| Q2 24 | $-1.8M | — | ||
| Q1 24 | $-3.8M | — |
| Q4 25 | — | $-71.3M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | — | $-80.8M | ||
| Q1 25 | — | $-87.0M | ||
| Q4 24 | — | $-87.3M | ||
| Q3 24 | — | $-101.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -186.2% | ||
| Q3 25 | — | -217.2% | ||
| Q2 25 | — | -305.9% | ||
| Q1 25 | — | -526.9% | ||
| Q4 24 | — | -1155.4% | ||
| Q3 24 | — | -1663.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 4.1% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | — | 45.7% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
